Endo, SkyePharma Cease Propofol IDD-D Agreement

Endo Pharmaceuticals dropped out as SkyePharma plc's North American development partner for Propofol IDD-D, leaving the future of the anesthetic in limbo as the London-based company decides the next steps. (BioWorld Today)